Literature DB >> 10669508

Effects of intracolonic opioid receptor agonists on polymodal pelvic nerve afferent fibers in the rat.

X Su1, V Julia, G F Gebhart.   

Abstract

We studied the effects of intracolonic administration of opioid receptor agonists (ORAs) on responses of pelvic nerve afferent fibers to colorectal distension (CRD) and heat. Single-fiber recordings were made from the decentralized S1 dorsal rootlet in the rat. An approximately 7-cm length of descending colon was isolated in situ to permit intracolonic perfusion with Krebs solution, which, when the outflow was clamped, was used to distend the colon. Responses to noxious CRD (40 mmHg, 30 s) were tested after intracolonic instillation of mu-, delta- or kappa-ORAs. Intracolonic administration of the kappa-ORAs EMD 61,753 (n = 5/12) and U62,066 (n = 8/11), but not either the mu-ORA fentanyl or the delta-ORA SNC-80, concentration-dependently inhibited responses of afferent fibers. For fibers unaffected by intracolonic administration of EMD 61,753 or U62,066, intra-arterial administration of kappa-ORAs was effective. Forty-one of 54 mechanosensitive fibers also responded to intracolonic instillation of heated Krebs solution (50 degrees C). Intra-arterial injection of fentanyl or SNC-80 did not attenuate responses to heat. Either intracolonic or intra-arterial administration of EMD 61,753 or U62, 066, however, inhibited afferent fiber responses to heat. These results document that mechanical and thermal sensitivity of polymodal pelvic nerve afferent fibers innervating the rat colon can be inhibited peripherally by intracolonic instillation of kappa-ORAs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10669508     DOI: 10.1152/jn.2000.83.2.963

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  9 in total

Review 1.  Treating irritable bowel syndrome: overview, perspective and future therapies.

Authors:  Michael Camilleri
Journal:  Br J Pharmacol       Date:  2004-03-22       Impact factor: 8.739

2.  Opioid-induced bowel dysfunction.

Authors:  Howard Y Chang; Anthony J Lembo
Journal:  Curr Treat Options Gastroenterol       Date:  2008-02

Review 3.  Recommendations for evaluation of bladder and bowel function in pre-clinical spinal cord injury research.

Authors:  Gregory M Holmes; Charles H Hubscher; Andrei Krassioukov; Lyn B Jakeman; Naomi Kleitman
Journal:  J Spinal Cord Med       Date:  2019-09-26       Impact factor: 1.985

4.  kappa -opioid receptor agonists modulate visceral nociception at a novel, peripheral site of action.

Authors:  S K Joshi; X Su; F Porreca; G F Gebhart
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

Review 5.  Kappa opioids and the modulation of pain.

Authors:  Bronwyn Kivell; Thomas E Prisinzano
Journal:  Psychopharmacology (Berl)       Date:  2010-04-07       Impact factor: 4.530

Review 6.  IBS--review and what's new.

Authors:  Amy Foxx-Orenstein
Journal:  MedGenMed       Date:  2006-07-26

Review 7.  Visceral pain.

Authors:  S K Joshi; G F Gebhart
Journal:  Curr Rev Pain       Date:  2000

Review 8.  Functional GI disorders: from animal models to drug development.

Authors:  E A Mayer; S Bradesi; L Chang; B M R Spiegel; J A Bueller; B D Naliboff
Journal:  Gut       Date:  2007-10-26       Impact factor: 23.059

Review 9.  Novel pharmacology: asimadoline, a kappa-opioid agonist, and visceral sensation.

Authors:  M Camilleri
Journal:  Neurogastroenterol Motil       Date:  2008-09       Impact factor: 3.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.